Delfraissy, Jean-François, 1948-...., médecin
Delfraissy, Jean-François
Jean-François Delfraissy médecin et professeur de médecine français
Delfraissy, Jean-François, 1948-
VIAF ID: 44317387 (Personal)
Permalink: http://viaf.org/viaf/44317387
Preferred Forms
- 200 _ 1 ‡a Delfraissy ‡b , Jean François
-
- 100 1 _ ‡a Delfraissy, Jean François
- 100 1 _ ‡a Delfraissy, Jean-François
- 100 1 _ ‡a Delfraissy, Jean-François ‡d 1948-
-
- 100 1 _ ‡a Delfraissy, Jean-François, ‡d 1948-...., ‡c médecin
-
- 100 0 _ ‡a Jean-François Delfraissy ‡c médecin et professeur de médecine français
4xx's: Alternate Name Forms (6)
5xx's: Related Names (2)
Works
Title | Sources |
---|---|
365 nouvelles maladies | |
Le 365 nuove malattie / Jean Dormont, Olivier Blétry, Jean-Francois Delfraissy ; ed. italiana a cura di Bruno Del Grosso, Carla Petrassi | |
40 ans de bioéthique en France : le Comité consultatif national d'éthique: 1983-2023 / sous la direction de Jean-François Delfraissy, Emmanuel Didier, Pierre-Henri Duée | |
Anévrisme disséquant primitif de l'artère rénale avec hypertension artérielle à propos d'un cas, revue de la littérature | |
ANTICOAGULANT CIRCULANT ET AVORTEMENTS A REPETITION : AMELIORATION DU PRONOSTIC FOETAL PAR L'ADMINISTRATION PRECOCE DE CORTICOIDES ET D'ASPIRINE AU COURS DE LA GROSSESSE | |
La bioéthique en débat : le début de la vie | |
CD4+ cell count recovery in naïve patients initiating cART, who achieved and maintained plasma HIV-RNA suppression | |
Chronic inflammation and immune activation in HIV controller patients : Relationships with the antiviral control and involvement of the IFN pathways. | |
Cities central to HIV response for people who use drugs | |
Claudin-6 and Occludin Natural Variants Found in a Patient Highly Exposed but Not Infected with Hepatitis C Virus (HCV) Do Not Confer HCV Resistance In Vitro | |
Délétion CCR5-delta 32 et progression de la maladie VIH-1 | |
Despite being highly diverse, immunovirological status strongly correlates with clinical symptoms during primary HIV-1 infection: a cross-sectional study based on 674 patients enrolled in the ANRS CO 06 PRIMO cohort | |
Distinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: the ANRS Genome Wide Association 01 study | |
Dyslipidemias and Elevated Cardiovascular Risk on Lopinavir-Based Antiretroviral Therapy in Cambodia | |
Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: a randomized controlled trial | |
Effets de l'interleukine-12 et de l'activation CD40 sur les cellules présentatrices de l'antigène | |
Efficacy and tolerability of a nucleoside reverse transcriptase inhibitor-sparing combination of lopinavir/ritonavir and efavirenz in HIV-1-infected patients | |
Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia | |
Efficacy of mycophenolate mofetil in adult refractory auto-immune cytopenias: a single center preliminary study | |
L’équité hors du droit | |
Éthique en mouvement | |
ETUDE DE LA FONCTION T CD4+ SPECIFIQUE CHEZ DES PATIENTS SOUS TRAITEMENT ANTIRETROVIRAL EFFICACE AU LONG COURS (DES PHARMACIE SPECIALISEE) | |
ETUDE DE LA PRODUCTION D'INTERLEUKINE 12 PAR LE MONOCYTE ET LE MACROPHAGE ET DE SES MODIFICATIONS LORS DE L'INFECTION PAR LE VIRUS DE L'IMMUNODEFICIENCE HUMAINE | |
ETUDE DU PASSAGE TRANSPLACENTAIRE DE L'AZT ET DU DDI AU 2EME TRIMESTRE DE LA GROSSESSE CHEZ LES FEMMES INFECTEES PAR LE VIH | |
Face à la pandémie : les avis du Conseil scientifique COVID-19 | |
Feasibility of antenatal and late HIV testing in pregnant women in Phnom Penh Cambodia: the PERIKAM/ANRS1205 study | |
Femmes et VIH en France | |
Genomewide association study of a rapid progression cohort identifies new susceptibility alleles for AIDS (ANRS Genomewide Association Study 03). | |
Genotypic drug resistance during HIV-1 primary infection in France (1996-1999): frequency and response to treatment | |
Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers | |
High efficacy of lopinavir/r-based second-line antiretroviral treatment after 24 months of follow up at ESTHER/Calmette Hospital in Phnom Penh, Cambodia | |
HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication | |
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype | |
HIV infection: pre-highly active antiretroviral therapy IL-7 plasma levels correlate with long-term CD4 cell count increase after treatment. | |
Hope for the eradication of HCV worldwide | |
Identification and biochemical characterization of human plasma soluble IL-7R: lower concentrations in HIV-1-infected patients | |
Immuno-virological features of HIV reservoirs. | |
Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy | |
Inflammation chronique et hyperactivation du système immunitaire chez les patients HIV controllers : liens avec le contrôle antiviral et la mise en jeu de la voie des interférons | |
Interleukin-7 (IL-7): immune function, involvement in the pathogenesis of HIV infection and therapeutic potential. | |
L' intimité menacée ? : enjeux éthiques dans la pratique du soin et de l'accompagnement | |
The lymphocyte HIV reservoir in patients on long-term HAART is a memory of virus evolution | |
[Management of patients infected by the human immunodeficiency virus | |
médecin au front | |
Modéliser la propagation et le contrôle du SARS-CoV-2 en France | |
Modelling the spread and control of SARS-CoV-2 in France. | |
Multicohort genomewide association study reveals a new signal of protection against HIV-1 acquisition | |
Néphrologie, urologie | |
nouvelle loi de bioéthique en question(s) | |
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection | |
Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial | |
Parcours : parcours de vie et santé des Africains immigrés en France | |
personnes âgées au risque de la pandémie | |
Pharmacokinetics and pharmacogenetics of nevirapine and efavirenz in HIV-infected Cambodian patients. | |
Post-exposure prophylaxis with a maraviroc-containing regimen after occupational exposure to a multi-resistant HIV-infected source person | |
Primary HIV-1 infection : impact of clinical and immunological patient characteristics in terms of therapeutic decision. | |
Prise en charge des personnes infectées par le VIH rapport 2002 recommandations du groupe d'experts | |
Prognostic factors for virological response in antiretroviral therapy-naive patients in the MONARK Trial randomized to ritonavir-boosted lopinavir alone | |
Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir | |
Protéger les majeurs vulnérables. | |
Psychiatrie, VIH et hépatite C : quels enjeux de santé publique ? : quels enjeux pour la psychiatrie ? | |
Public T cell receptors confer high-avidity CD4 responses to HIV controllers | |
Questions d'éthique au temps de la Covid-19 avis du CCNE et du CNPEN, 2020-2021 | |
Randomised controlled trials for Ebola: practical and ethical issues | |
Reconstitution inflammatory syndrome related to histoplasmosis, with a hemophagocytic syndrome in HIV infection | |
Réflexion et recherches en éthique : mélanges en l'honneur du professeur Christian Hervé | |
Reply | |
Risk factors for hepatitis C transmission in HIV patients, Hepacam study, ANRS 12267 Cambodia | |
Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial | |
Ritonavir-boosted protease inhibitor monotherapy for the treatment of HIV-1 infection. | |
Safety and immunogenicity of a monovalent 2009 influenza A/H1N1v vaccine adjuvanted with AS03A or unadjuvanted in HIV-infected adults: a randomized, controlled trial | |
Screening low-frequency SNPS from genome-wide association study reveals a new risk allele for progression to AIDS | |
Short communication: three years follow-up of first-line antiretroviral therapy in cambodia: negative impact of prior antiretroviral treatment | |
SIDA : une maladie chronique passée au crible : enquête nationale sur le quotidien des personnes infectées | |
State humanitarian verticalism versus universal health coverage: a century of French international health assistance revisited | |
Switching to darunavir/ritonavir achieves viral suppression in patients with persistent low replication on first-line lopinavir/ritonavir | |
TB-IRIS, T-cell activation, and remodeling of the T-cell compartment in highly immunosuppressed HIV-infected patients with TB | |
TORO: ninety-six-week virologic and immunologic response and safety evaluation of enfuvirtide with an optimized background of antiretrovirals | |
Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure. | |
TOXICOMANES INCARCERES A L'HOPITAL DE FRESNES : ASPECTS SOCIAUX ; MORBILITE ; HISTOIRE INSTITUTIONNELLE | |
Trends in unsafe sex and influence of viral load among patients followed since primary HIV infection, 2000-2009. | |
Variabilité pharmacocinétique de la névirapine et de l'éfavirenz et rôle du polymorphisme des enzymes et transporteurs dans une population de patients cambodgiens infectés par le VIH et traités par une association d'antirétroviraux comprenant névirapine ou éfavirenz | |
La vie, le corps et la mort : réflexion juridique et éthique | |
VIH ET GROSSESSE : ETUDE RETROSPECTIVE SUR LES FEMMES ENCEINTES SEROPOSITIVES DANS 3 MATERNITES DE LA REGION PARISIENNE | |
Virus et grossesse | |
প্রত্যুত্তর |